See more : Coca-Cola Consolidated, Inc. (0I0T.L) Income Statement Analysis – Financial Results
Complete financial analysis of OLBA HEALTHCARE HOLDINGS, Inc. (2689.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of OLBA HEALTHCARE HOLDINGS, Inc., a leading company in the Medical – Distribution industry within the Healthcare sector.
- RPG Life Sciences Limited (RPGLIFE.BO) Income Statement Analysis – Financial Results
- Advanced Process Systems Corporation (265520.KQ) Income Statement Analysis – Financial Results
- Ipsen S.A. (IPSEY) Income Statement Analysis – Financial Results
- Silver X Mining Corp. (AGXPF) Income Statement Analysis – Financial Results
- Limitless X Holdings Inc. (BLAB) Income Statement Analysis – Financial Results
OLBA HEALTHCARE HOLDINGS, Inc. (2689.T)
About OLBA HEALTHCARE HOLDINGS, Inc.
OLBA HEALTHCARE HOLDINGS, Inc. provides various solutions to medical institutions, universities, corporate research institutes, individuals, and long-term care facilities in Japan. The company's medical equipment business engages in the wholesale of artificial joints, pacemakers, coronary stents, steel instruments, and ultrasonic scalpels; and diagnostic imaging equipment, such as MRI and CT to respirators, intraoperative monitors, and surgical lights. It also offers reagents and equipment for genetic research, cell culture, and protein analysis; automatic analyzers for biochemistry, immunity, and blood; and test reagents, as well as undertakes services for DNA analysis in the field of life sciences. The company's Supply Processing and Distribution business provides goods management, information management, and purchase management services. Its Nursing care products business engages in the rental of nursing care equipment; sale of welfare equipment, such as portable toilets and bathing equipment; and operation of long-term care reform, a comfortable stay at home. The company was formerly known as Kawanishi Holdings, Inc. and changed its name to OLBA HEALTHCARE HOLDINGS, Inc. in January 2021. OLBA HEALTHCARE HOLDINGS, Inc. was founded in 1921 and is headquartered in Okayama, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 118.56B | 110.47B | 107.96B | 112.98B | 107.90B | 107.43B | 107.66B | 105.78B | 101.46B | 94.52B | 97.14B | 96.22B | 74.74B | 62.14B | 58.86B | 55.00B | 54.38B |
| Cost of Revenue | 104.96B | 97.52B | 95.46B | 101.38B | 96.83B | 96.29B | 96.64B | 94.88B | 91.33B | 84.76B | 87.02B | 86.15B | 66.85B | 55.53B | 52.67B | 49.02B | 48.37B |
| Gross Profit | 13.60B | 12.95B | 12.50B | 11.60B | 11.07B | 11.14B | 11.02B | 10.90B | 10.14B | 9.76B | 10.12B | 10.08B | 7.90B | 6.61B | 6.19B | 5.98B | 6.01B |
| Gross Profit Ratio | 11.47% | 11.73% | 11.58% | 10.27% | 10.26% | 10.37% | 10.24% | 10.30% | 9.99% | 10.32% | 10.42% | 10.47% | 10.56% | 10.63% | 10.51% | 10.88% | 11.05% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 329.00M | 366.00M | 388.00M | 389.00M | 396.00M | 377.00M | 439.00M | 523.31M | 529.84M | 509.07M | 481.74M | 482.59M | 447.57M | 398.99M | 401.35M | 415.38M | 420.80M |
| Selling & Marketing | 11.05B | 10.44B | 10.04B | 9.67B | 9.74B | 9.46B | 9.35B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 11.37B | 10.81B | 10.43B | 10.06B | 10.14B | 9.84B | 9.79B | 523.31M | 529.84M | 509.07M | 481.74M | 482.59M | 447.57M | 398.99M | 401.35M | 415.38M | 420.80M |
| Other Expenses | 0.00 | 21.00M | 132.40M | 39.71M | 24.90M | 26.75M | 19.57M | 90.05M | 42.58M | 32.41M | 119.99M | 36.53M | 33.71M | 24.47M | 20.07M | 18.53M | 31.44M |
| Operating Expenses | 11.37B | 10.80B | 10.43B | 10.06B | 10.14B | 9.84B | 9.79B | 6.21B | 5.95B | 5.53B | 5.28B | 5.15B | 4.36B | 3.69B | 3.49B | 3.40B | 3.36B |
| Cost & Expenses | 116.34B | 108.32B | 105.89B | 111.44B | 106.97B | 106.13B | 106.43B | 101.09B | 97.27B | 90.29B | 92.29B | 91.29B | 71.20B | 59.22B | 56.16B | 52.42B | 51.73B |
| Interest Income | 4.03M | 463.00K | 315.00K | 401.00K | 366.00K | 537.00K | 405.00K | 633.00K | 1.06M | 2.31M | 1.53M | 1.69M | 2.68M | 2.04M | 2.65M | 3.48M | 3.47M |
| Interest Expense | 19.43M | 17.85M | 20.52M | 22.10M | 26.41M | 21.04M | 18.95M | 22.19M | 30.23M | 32.67M | 43.35M | 60.18M | 53.86M | 45.36M | 51.75M | 63.35M | 77.24M |
| Depreciation & Amortization | 564.87M | 510.12M | 403.45M | 402.08M | 410.50M | 361.89M | 315.54M | 312.25M | 396.96M | 396.03M | 360.52M | 365.18M | 332.23M | 267.16M | 273.63M | 1.10B | 255.44M |
| EBITDA | 2.83B | 2.68B | 2.56B | 1.94B | 1.16B | 1.56B | 1.72B | 1.45B | 998.45M | 1.11B | 1.87B | 2.02B | 1.11B | 909.67M | 785.94M | 510.00M | 725.04M |
| EBITDA Ratio | 2.38% | 2.43% | 2.44% | 1.74% | 1.24% | 1.58% | 1.46% | 4.82% | 4.56% | 4.93% | 5.49% | 5.54% | 5.23% | 5.17% | 5.09% | 6.73% | 5.40% |
| Operating Income | 2.23B | 2.15B | 2.07B | 1.54B | 927.03M | 1.30B | 1.23B | 1.04B | 543.45M | 668.19M | 1.44B | 1.56B | 766.77M | 593.16M | 490.12M | 322.81M | 419.22M |
| Operating Income Ratio | 1.88% | 1.95% | 1.92% | 1.36% | 0.86% | 1.21% | 1.14% | 0.99% | 0.54% | 0.71% | 1.48% | 1.62% | 1.03% | 0.95% | 0.83% | 0.59% | 0.77% |
| Total Other Income/Expenses | 16.58M | 5.36M | 63.68M | -27.36M | -204.63M | -119.49M | 151.04M | 70.13M | 27.81M | 9.53M | 26.00M | 41.12M | -39.24M | 3.99M | -27.35M | -957.52M | -26.86M |
| Income Before Tax | 2.24B | 2.16B | 2.14B | 1.51B | 722.40M | 1.18B | 1.38B | 1.11B | 571.26M | 677.73M | 1.47B | 1.60B | 727.53M | 597.15M | 462.76M | -634.72M | 392.36M |
| Income Before Tax Ratio | 1.89% | 1.95% | 1.98% | 1.34% | 0.67% | 1.10% | 1.28% | 1.05% | 0.56% | 0.72% | 1.51% | 1.66% | 0.97% | 0.96% | 0.79% | -1.15% | 0.72% |
| Income Tax Expense | 742.90M | 742.30M | 601.49M | 524.04M | 481.57M | 445.86M | 338.78M | 432.53M | 265.55M | 272.47M | 650.27M | 653.96M | 381.50M | 284.88M | 238.81M | 145.44M | 255.07M |
| Net Income | 1.50B | 1.41B | 1.54B | 989.37M | 326.41M | 775.58M | 1.05B | 690.65M | 305.71M | 405.26M | 816.58M | 943.28M | 346.03M | 312.27M | 223.96M | -780.16M | 137.30M |
| Net Income Ratio | 1.27% | 1.28% | 1.42% | 0.88% | 0.30% | 0.72% | 0.98% | 0.65% | 0.30% | 0.43% | 0.84% | 0.98% | 0.46% | 0.50% | 0.38% | -1.42% | 0.25% |
| EPS | 251.68 | 234.90 | 252.80 | 162.66 | 56.76 | 138.24 | 187.86 | 123.10 | 54.49 | 72.23 | 145.54 | 168.12 | 61.67 | 55.65 | 39.91 | -139.04 | 24.47 |
| EPS Diluted | 251.68 | 234.90 | 252.80 | 162.66 | 56.76 | 138.24 | 187.86 | 123.10 | 54.49 | 72.23 | 145.54 | 168.12 | 61.67 | 55.65 | 39.91 | -139.04 | 24.47 |
| Weighted Avg Shares Out | 5.96M | 6.02M | 6.07M | 6.08M | 5.75M | 5.61M | 5.61M | 5.61M | 5.61M | 5.61M | 5.61M | 5.61M | 5.61M | 5.61M | 5.61M | 5.61M | 5.61M |
| Weighted Avg Shares Out (Dil) | 5.96M | 6.02M | 6.07M | 6.08M | 5.75M | 5.61M | 5.61M | 5.61M | 5.61M | 5.61M | 5.61M | 5.61M | 5.61M | 5.61M | 5.61M | 5.61M | 5.61M |
Source: https://incomestatements.info
Category: Stock Reports